Alalmaie A, Alshahrani H, Alqahtani M, Alshahrani Z, Alahmari S, Asiri A
Front Med Technol. 2025; 7:1528826.
PMID: 40066057
PMC: 11892449.
DOI: 10.3389/fmedt.2025.1528826.
Hsu J, Lau K, Barragan D, Mossburg K, Cormode D, Maidment A
ACS Appl Nano Mater. 2025; 7(5):4805-4813.
PMID: 39882402
PMC: 11774497.
DOI: 10.1021/acsanm.3c05431.
Rosario-Berrios D, Pang A, Liu L, Maidment P, Kim J, Yoon S
Bioconjug Chem. 2025; 36(2):233-244.
PMID: 39786354
PMC: 11839313.
DOI: 10.1021/acs.bioconjchem.4c00507.
Gary R, Ben Salah M, Soltani T, Formoso P, Hbaieb S
ACS Omega. 2024; 9(50):49530-49538.
PMID: 39713617
PMC: 11656202.
DOI: 10.1021/acsomega.4c07393.
Butt A, Bach H
Nanomedicine (Lond). 2024; 20(2):183-206.
PMID: 39670826
PMC: 11730800.
DOI: 10.1080/17435889.2024.2439778.
Preparation and Complex Characterisation of Stabilised Gold Nanoparticles: Biodistribution and Application for High Resolution In Vivo Imaging.
Turanek J, Knotigova P, Kulich P, Skoupy R, Hrubanova K, Vaskovicova N
Pharmaceuticals (Basel). 2024; 17(11).
PMID: 39598391
PMC: 11597195.
DOI: 10.3390/ph17111479.
Nanoparticles as a novel key driver for the isolation and detection of circulating tumour cells.
Bashir S, Zia M, Shoukat M, Kaleem I, Bashir S
Sci Rep. 2024; 14(1):22580.
PMID: 39343959
PMC: 11439955.
DOI: 10.1038/s41598-024-67221-4.
Identification of the Vulnerability of Atherosclerotic Plaques by a Photoacoustic/Ultrasonic Dual-Modal cRGD Nanomolecular Probe.
Yu C, Zhong L, Zhou Y, Jiang N, Chen J, Cao S
Int J Nanomedicine. 2024; 19:9395-9410.
PMID: 39282572
PMC: 11402356.
DOI: 10.2147/IJN.S476236.
In Vitro Evaluation of DNA Damage Induction by Silver (Ag), Gold (Au), Silica (SiO), and Aluminum Oxide (AlO) Nanoparticles in Human Peripheral Blood Mononuclear Cells.
Babonaite M, Striogaite E, Grigorianaite G, Lazutka J
Curr Issues Mol Biol. 2024; 46(7):6986-7000.
PMID: 39057058
PMC: 11276609.
DOI: 10.3390/cimb46070417.
[F]-Radiolabelled Nanoplatforms: A Critical Review of Their Intrinsic Characteristics, Radiolabelling Methods, and Purification Techniques.
Deleuziere M, Benoist E, Quelven I, Gras E, Amiens C
Molecules. 2024; 29(7).
PMID: 38611815
PMC: 11013168.
DOI: 10.3390/molecules29071537.
Hybridized quantum dot, silica, and gold nanoparticles for targeted chemo-radiotherapy in colorectal cancer theranostics.
Abrishami A, Bahrami A, Nekooei S, Saljooghi A, Matin M
Commun Biol. 2024; 7(1):393.
PMID: 38561432
PMC: 10984983.
DOI: 10.1038/s42003-024-06043-6.
Gold nanoparticle-mediated photothermal therapy guidance with multi-wavelength photomagnetic imaging.
Nouizi F, Algarawi M, Erkol H, Gulsen G
Photodiagnosis Photodyn Ther. 2023; 45:103956.
PMID: 38159834
PMC: 11396545.
DOI: 10.1016/j.pdpdt.2023.103956.
Nanomaterial-based contrast agents.
Hsu J, Tang Z, Eremina O, Sofias A, Lammers T, Lovell J
Nat Rev Methods Primers. 2023; 3.
PMID: 38130699
PMC: 10732545.
DOI: 10.1038/s43586-023-00211-4.
A Biodegradable "One-For-All" Nanoparticle for Multimodality Imaging and Enhanced Photothermal Treatment of Breast Cancer.
Hsu J, Barragan D, Tward A, Hajfathalian M, Amirshaghaghi A, Mossburg K
Adv Healthc Mater. 2023; 13(8):e2303018.
PMID: 38117252
PMC: 10965380.
DOI: 10.1002/adhm.202303018.
A shift in focus towards precision oncology, driven by revolutionary nanodiagnostics; revealing mysterious pathways in colorectal carcinogenesis.
Sharma S, Bhattacharya S, Joshi K, Singh S
J Cancer Res Clin Oncol. 2023; 149(17):16157-16177.
PMID: 37650995
DOI: 10.1007/s00432-023-05331-8.
Tunable-wavelength nanosecond laser tailoring of plasmon resonance spectra of gold nanoparticle colloids.
Sukmanee T, Szuster M, Gorski A, Holdynski M, Gawinkowski S
Nanoscale Adv. 2023; 5(14):3697-3704.
PMID: 37441263
PMC: 10334372.
DOI: 10.1039/d3na00225j.
Multispectral optoacoustic tomography is more sensitive than micro-computed tomography for tracking gold nanorod labelled mesenchymal stromal cells.
Pichardo A, Littlewood J, Taylor A, Wilm B, Levy R, Murray P
J Biophotonics. 2023; 16(10):e202300109.
PMID: 37431566
PMC: 7616740.
DOI: 10.1002/jbio.202300109.
The use of plant-derived exosome-like nanoparticles as a delivery system of CRISPR/Cas9-based therapeutics for editing long non-coding RNAs in cancer colon cells.
Hillman T
Front Oncol. 2023; 13:1194350.
PMID: 37388221
PMC: 10301836.
DOI: 10.3389/fonc.2023.1194350.
Carbon Dots: Opportunities and Challenges in Cancer Therapy.
Bhattacharya T, Shin G, Kim J
Pharmaceutics. 2023; 15(3).
PMID: 36986879
PMC: 10059251.
DOI: 10.3390/pharmaceutics15031019.
Metal Sulfide Nanoparticles for Imaging and Phototherapeutic Applications.
Shetty A, Lang H, Chandra S
Molecules. 2023; 28(6).
PMID: 36985525
PMC: 10051882.
DOI: 10.3390/molecules28062553.